Brinker Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $1.24M | Buy |
11,037
+701
| +7% | +$78.7K | 0.04% | 444 |
|
|
2020
Q1 | $928K | Buy |
10,336
+3,096
| +43% | +$278K | 0.04% | 445 |
|
|
2019
Q4 | $783K | Sell |
7,240
-1,611
| -18% | -$174K | 0.02% | 586 |
|
|
2019
Q3 | $867K | Buy |
8,851
+684
| +8% | +$67K | 0.03% | 535 |
|
|
2019
Q2 | $1.07M | Sell |
8,167
-1,909
| -19% | -$250K | 0.04% | 445 |
|
|
2019
Q1 | $1.36M | Buy |
10,076
+3,364
| +50% | +$455K | 0.05% | 370 |
|
|
2018
Q4 | $653K | Sell |
6,712
-870
| -11% | -$84.6K | 0.03% | 527 |
|
|
2018
Q3 | $1.05M | Buy |
7,582
+1,804
| +31% | +$251K | 0.04% | 484 |
|
|
2018
Q2 | $717K | Buy |
5,778
+93
| +2% | +$11.5K | 0.03% | 599 |
|
|
2018
Q1 | $634K | Buy |
5,685
+962
| +20% | +$107K | 0.02% | 630 |
|
|
2017
Q4 | $565K | Buy |
4,723
+159
| +3% | +$19K | 0.02% | 649 |
|
|
2017
Q3 | $640K | Buy |
+4,564
| New | +$640K | 0.03% | 580 |
|
|
2017
Q2 | – | Sell |
-3,493
| Closed | -$423K | – | 921 |
|
|
2017
Q1 | $423K | Sell |
3,493
-560
| -14% | -$67.8K | 0.02% | 649 |
|
|
2016
Q4 | $496K | Buy |
+4,053
| New | +$496K | 0.03% | 456 |
|